Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.
A benign epithelial tumor of the LIVER.
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Tumors or cancer of the LIVER.
A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
Pathological processes of the LIVER.
Substances used to allow enhanced visualization of tissues.
Sulfur hexafluoride. An inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants.
A type II keratin found associated with KERATIN-19 in ductal epithelia and gastrointestinal epithelia.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
Computed tomography where there is continuous X-ray exposure to the patient while being transported in a spiral or helical pattern through the beam of irradiation. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.
A type I keratin found associated with KERATIN-7 in ductal epithelia and gastrointestinal epithelia.
Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural MICROSCOPY, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level.
A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Excision of all or part of the liver. (Dorland, 28th ed)
Radiography of blood vessels after injection of a contrast medium.
Polysaccharides are complex carbohydrates consisting of long, often branched chains of repeating monosaccharide units joined together by glycosidic bonds, which serve as energy storage molecules (e.g., glycogen), structural components (e.g., cellulose), and molecular recognition sites in various biological systems.
Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
The abundant submucosal mucous glands in the DUODENUM. These glands secrete BICARBONATE IONS; GLYCOPROTEINS; and PEPSINOGEN II.

Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. (1/97)

The number of dysplastic nodules detected clinically has increased since patients with hepatitis virus-associated cirrhosis, who are at increased risk for hepatocellular carcinoma (HCC), began to undergo regular cancer surveillance. Although it is potentially important to determine which type(s) of nodule may be prone to progress to HCC, outcomes of dysplastic nodules have not been fully investigated. This prompted us to examine the outcomes of dysplastic nodules in cirrhotic patients clinicopathologically. We studied 33 dysplastic nodules of <20 mm in maximum diameter, diagnosed by fine needle aspiration biopsy under ultrasonography (US). These nodules were clinically followed, mainly by US examination, for up to 70 months. When the nodules enlarged or exhibited changes on US, they were histologically reexamined by second biopsy. Surprisingly, 15 of the 33 nodules (45.5%) disappeared, 14 nodules (42.4%) remained unchanged, and only 4 nodules (12.1%) progressed to HCC. The latter 4 nodules were all hyperechoic on US and were composed of clear cells with fatty change or small cells with increased nuclear density, and in all 4 patients serum was positive for hepatitis C virus antibody. Univariate analyses revealed that, although not significant, the hyperechoic nodules or nodules with small cell change showed a higher HCC progression rate in comparison with the hypoechoic nodules or the nodules without small cell change. In summary, most of the dysplastic nodules we followed disappeared or remained unchanged, but some progressed to HCC. Hyperechoic nodules in patients with hepatitis C virus-associated cirrhosis, which show small cell change with increased nuclear density, may be prone to progress to HCC.  (+info)

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. (2/97)

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is a common malignant tumour worldwide, and its differential diagnosis from benign lesions of the liver is often difficult yet of great clinical importance. In the present study, we analysed whether glypican-3 is useful in differentiating between benign and malignant liver diseases and whether it influences the growth behaviour of HCC. METHODS: Northern blot analysis and in situ hybridisation. RESULTS: Northern blot analysis indicated that expression of glypican-3 mRNA was either low or absent in normal liver, in focal nodular hyperplasia (FNH), and in liver cirrhosis. In contrast, expression of glypican-3 mRNA was markedly increased in 20 of 30 and moderately increased in five of 30 HCC samples. The average increase in glypican-3 mRNA expression in HCC was significant compared with expression in normal liver (21.7-fold increase, p<0.01). In comparison with FNH or liver cirrhosis, glypican-3 mRNA expression in HCC was increased 7.2- (p<0.05) and 10.8-fold (p<0.01), respectively. In addition, pushing HCCs exhibited significantly higher glypican-3 mRNA expression than invading tumours (p<0.05). In situ hybridisation analysis demonstrated weak expression of glypican-3 mRNA in normal hepatocytes and bile ductular cells, and weak to occasionally moderate signals in hepatocytes forming nodules of liver cirrhosis and in regenerated hepatic nodules of FNH. In contrast, glypican-3 in situ hybridisation signals were intense in hepatic cancer cells with even higher levels in pushing HCCs than in invading HCCs. CONCLUSIONS: These findings suggest that glypican-3, in many cases, has the potential to differentiate between benign and malignant liver diseases.  (+info)

Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR. (3/97)

Hepatitis C virus is a major risk factor for hepatocarcinogenesis in humans. In situ detection of the virus in early sequential lesions of hepatocarcinogenesis could provide information about the role of the virus in the transformation and promotion process. Parallel in situ detection of HCV proteins and RNA in human tissues were performed in 55 posthepatitis C cirrhosis, 17 dysplastic nodules (DN), and 25 hepatocellular carcinomas (HCC), using immunohistochemistry and tissue quantitative RT-PCR. A consistent cytoplasmic hepatocellular staining was obtained in 73% of cirrhosis cases (with or without HCC) and in 55% DN cases. A few tumoral hepatocytes were unambiguously stained in 28% HCC. The percentage of positive cells and the intensity of immunostaining significantly decreased from cirrhosis to HCC through DN, whereas there was no difference in the prevalence of positivity or the number of viral copies between cirrhosis and HCC using tissue-quantitative RT-PCR. Finally, RT-PCR levels were found parallel with the immunostaining in cirrhosis but not in HCC. These results suggest that HCV protein synthesis may persist but be down-regulated during sequential hepatocarcinogenesis. A putative role of HCV proteins on cell proliferation and differentiation during the early steps of carcinogenesis cannot therefore be excluded.  (+info)

Hepatic toxicity and recovery of Fischer 344 rats following exposure to 2-aminoanthracene by intraperitoneal injection. (4/97)

Humans may be exposed to 2-aminoanthracene (2-AA), a substituted polycyclic aromatic hydrocarbon, and a recognized mutagen and carcinogen, through oral and respiratory routes from contact with a variety of environmental sources. For the present study, we sought to evaluate hepatic damage and recovery in Fischer 344 rats following multiple i.p. injections of 5 mg of 2-AA. Rats were injected weekly for up to 5 weeks. Subgroups were then allowed to recover for 1, 5, or 9 weeks, and biochemical and pathologic changes were evaluated. We observed that weight gains were reduced relative to controls for all groups receiving > or = 2 injections. Serum enzyme levels indicative of liver damage were evident and included alterations in serum aspartate aminotransferase, alkaline phosphatase, total protein, albumin, and globulin. These alterations usually returned to normal by 5 weeks following cessation of 2-AA administration. In contrast, histologic liver changes, including hepatocyte hypertrophy, biliary hyperplasia with oval cell proliferation, altered foci, nodular hyperplasia, and one hepatocellular adenoma became more severe with time. This experiment demonstrates patterns of hepatic damage and recovery in rats exposed to 2-AA.  (+info)

Successful outcome after transplantation of a donor liver with focal nodular hyperplasia. (5/97)

Because of the increasing gap in the number of patients awaiting organ transplantation and the supply of organ donors, reevaluation of donor criteria is an important issue in clinical transplantation. It has become necessary to make maximal use of the currently available donor pool. We describe a case of successful orthotopic liver transplantation in a 57-year-old man with Laennec's cirrhosis using a liver containing an 8-cm focal nodular hyperplasia (FNH) lesion involving segments II and III and the caudate lobe. The donor liver was procured from a 46-year-old woman declared brain dead after a subarachnoid hemorrhage. Definitive pathological diagnosis was made at laparotomy by obtaining a Tru-cut (Allegiance Health Care Inc, Toronto, Ontario, Canada) core biopsy specimen. The recipient operation was performed uneventfully except for bleeding from the biopsy site. The patient did well postoperatively and was discharged on tacrolimus, mofetil mycophenolate, and prednisone therapy. He continues to thrive 2(1/2) years posttransplantation with no change in the size of the lesion. In well-selected donors, FNH should not be a contraindication for use in transplantation. However, FNH must be differentiated from hepatocellular adenoma. Although FNH has a benign course with little propensity for bleeding and almost no malignant potential, hepatic adenoma is reported to have a 15% to 33% chance of bleeding and rupture with a well-documented potential for neoplastic degeneration, making the liver unsuitable for donation.  (+info)

Experience with ultrasound scissors and blades (UltraCision) in open and laparoscopic liver resection. (6/97)

OBJECTIVE: The authors used new ultrasonically activated scissors and blades in open and laparoscopic liver resections to investigate their capabilities. SUMMARY BACKGROUND DATA: Despite standardized techniques for liver resection, the surgical death rate ranges from 4% to 20%. Dissection of liver parenchyma may cause considerable blood loss. Further complications include liver failure, hematoma, infections, and bile leakage. The surgical technique is an important factor in preventing intraoperative and postoperative complications. Various techniques have been developed for safe and careful dissection of the liver parenchyma. In addition to blunt dissection using the "finger fracture" technique, various ultrasonic dissectors, water jet dissectors, laser systems, and specially prepared suction devices have been used, but none of these techniques can achieve complete hemostasis during dissection. METHODS: The instrument was used in open and laparoscopic liver resections. It works by means of a longitudinally vibrating blade or scissors in tissue dissection, coagulation, and preparation. Denaturation of protein and coagulation of vessels up to 2 to 3 mm is possible as a result of the vibration. In this prospective study of a consecutively sampled case series of 41 patients, the author sought to gain experience in handling this instrument and in its capabilities, and they also measured the extent of intraoperative and postoperative blood loss. RESULTS: The UltraCision was used for 64 open liver resections in 39 patients and for 2 laparoscopic liver resections in 2 patients. Blood loss in laparoscopic resections was less than 50 mL; in open resections it averaged 820 mL. Eleven patients (28%) needed blood transfusions. There were no biliary leakages or abscesses. One patient died after postoperative bleeding leading to fatal liver failure after 4 weeks. Handling of the instrument and cutting and coagulation quality were satisfactory. CONCLUSIONS: The advantages over other resection techniques are limited heat and smoke generation and the lack of current flow through the patient. The handling and coagulation and cutting quality of the UltraCision appeared satisfactory and safe. The new instrument can be recommended for laparoscopic and open resections of the liver.  (+info)

Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation. (7/97)

OBJECTIVE: To investigate two rare benign lesions, hepatocellular adenoma (HCA) and focal nodular hyperplasia (FNH), and evaluate differential diagnosis. METHODS: Twenty-four consecutive patients with presumed HCA and FNH were studied at the Liver Cancer Institute from January 1996 to May 1999. Preoperative assessment included clinical evaluation, symptoms and laboratory tests. New imaging techniques were prospectively appraised in addition to usual techniques. All had hepatic resections and follow-up. Histologic examination of surgical specimens was obtained in all cases. RESULTS: In every instance, FNH was an incidental finding. FNH consists of nodular aggregates of cytologically normal hepatocytes with foci of intranocular bile duct proliferation. In this series, patients with HCA had larger tumors and more often were symptomatic but the occurrence was unrelated to oral contraceptive steroids (OCS) usage. Intralesional hemorrhage or necrosis is common, and was seen in 75% of cases. The best imaging procedure in the diagnosis of FNH was MRI. Color Doppler US was a useful adjunct, but CT lacked specificity, making histological diagnosis mandatory. All patients underwent tumor resected were tumor--free during the follow-up. CONCLUSIONS: FNH is a distinct histopathologic entity, and is distinguishable from HCA. FNH is a hyperplastic response by the liver parenchyma to a pre-existing arterial malformation. HCA is a liver neoplasia and has the potential of malignant transformation to HCC. Based on these findings, we believe that if the clinical suspicion of HCA or FNH is strong, resection is usually the best approach if technically feasible and histologic diagnosis is mandatory.  (+info)

Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? (8/97)

BACKGROUND: Focal nodular hyperplasia (FNH) of the liver is a benign hepatic lesion relatively common in women. No studies specifically designed to describe the presentation and imaging findings in males have been published. AIMS: The aims of this study were: (a) to describe the clinical and imaging findings in 18 men with FNH, and (b) to compare these data with those observed in 216 women with FNH observed during the same nine year period. PATIENTS AND METHODS: According to a final diagnosis of FNH assessed either by pathological examination or by magnetic resonance (MR), the medical charts of 18 men with FNH observed at our institution were reviewed. In order to compare clinical and MR presentations, the files of 216 women with a total of 291 FNH lesions, investigated during the same nine year period, were reviewed. RESULTS: Eighteen FNH lesions, with a mean diameter of 37.5 mm, were demonstrated in the 18 male patients. A total of 291 lesions with a mean diameter of 63.4 mm were comparatively demonstrated in 216 female patients. Mean age at diagnosis was significantly higher in men (p<0.01) and mean FNH size was significantly smaller in men (p<0.001). Surgery was more frequently performed in men (72.2%) than in women (16.7%) (p<0.001). CONCLUSIONS: Our data indicate that FNH is rare in men and that the lesions are smaller and more often atypical than those in women.  (+info)

Focal nodular hyperplasia (FNH) is a benign liver mass, which means it's a non-cancerous growth. It is characterized by the presence of multiple nodules or "lesions" in the liver that are well-circumscribed and have a distinctive "stars in the sky" appearance on histopathology. These lesions are composed of abnormal arrangements of liver cells, bile ducts, and blood vessels. FNH is usually discovered incidentally during imaging studies performed for unrelated reasons. It's more common in women than men, and while its cause remains unclear, it has been linked to hormonal factors. Most cases do not require treatment unless they become symptomatic or complications arise.

A liver cell adenoma is a benign tumor that develops in the liver and is composed of cells similar to those normally found in the liver (hepatocytes). These tumors are usually solitary, but multiple adenomas can occur, especially in women who have taken oral contraceptives for many years. Liver cell adenomas are typically asymptomatic and are often discovered incidentally during imaging studies performed for other reasons. In rare cases, they may cause symptoms such as abdominal pain or discomfort, or complications such as bleeding or rupture. Treatment options include monitoring with periodic imaging studies or surgical removal of the tumor.

Hyperplasia is a medical term that refers to an abnormal increase in the number of cells in an organ or tissue, leading to an enlargement of the affected area. It's a response to various stimuli such as hormones, chronic irritation, or inflammation. Hyperplasia can be physiological, like the growth of breast tissue during pregnancy, or pathological, like in the case of benign or malignant tumors. The process is generally reversible if the stimulus is removed. It's important to note that hyperplasia itself is not cancerous, but some forms of hyperplasia can increase the risk of developing cancer over time.

Liver neoplasms refer to abnormal growths in the liver that can be benign or malignant. Benign liver neoplasms are non-cancerous tumors that do not spread to other parts of the body, while malignant liver neoplasms are cancerous tumors that can invade and destroy surrounding tissue and spread to other organs.

Liver neoplasms can be primary, meaning they originate in the liver, or secondary, meaning they have metastasized (spread) to the liver from another part of the body. Primary liver neoplasms can be further classified into different types based on their cell of origin and behavior, including hepatocellular carcinoma, cholangiocarcinoma, and hepatic hemangioma.

The diagnosis of liver neoplasms typically involves a combination of imaging studies, such as ultrasound, CT scan, or MRI, and biopsy to confirm the type and stage of the tumor. Treatment options depend on the type and extent of the neoplasm and may include surgery, radiation therapy, chemotherapy, or liver transplantation.

A hemangioma is a benign (noncancerous) vascular tumor or growth that originates from blood vessels. It is characterized by an overgrowth of endothelial cells, which line the interior surface of blood vessels. Hemangiomas can occur in various parts of the body, but they are most commonly found on the skin and mucous membranes.

Hemangiomas can be classified into two main types:

1. Capillary hemangioma (also known as strawberry hemangioma): This type is more common and typically appears during the first few weeks of life. It grows rapidly for several months before gradually involuting (or shrinking) on its own, usually within the first 5 years of life. Capillary hemangiomas can be superficial, appearing as a bright red, raised lesion on the skin, or deep, forming a bluish, compressible mass beneath the skin.

2. Cavernous hemangioma: This type is less common and typically appears during infancy or early childhood. It consists of large, dilated blood vessels and can occur in various organs, including the skin, liver, brain, and gastrointestinal tract. Cavernous hemangiomas on the skin appear as a rubbery, bluish mass that does not typically involute like capillary hemangiomas.

Most hemangiomas do not require treatment, especially if they are small and not causing any significant problems. However, in cases where hemangiomas interfere with vital functions, impair vision or hearing, or become infected, various treatments may be considered, such as medication (e.g., corticosteroids, propranolol), laser therapy, surgical excision, or embolization.

Liver diseases refer to a wide range of conditions that affect the normal functioning of the liver. The liver is a vital organ responsible for various critical functions such as detoxification, protein synthesis, and production of biochemicals necessary for digestion.

Liver diseases can be categorized into acute and chronic forms. Acute liver disease comes on rapidly and can be caused by factors like viral infections (hepatitis A, B, C, D, E), drug-induced liver injury, or exposure to toxic substances. Chronic liver disease develops slowly over time, often due to long-term exposure to harmful agents or inherent disorders of the liver.

Common examples of liver diseases include hepatitis, cirrhosis (scarring of the liver tissue), fatty liver disease, alcoholic liver disease, autoimmune liver diseases, genetic/hereditary liver disorders (like Wilson's disease and hemochromatosis), and liver cancers. Symptoms may vary widely depending on the type and stage of the disease but could include jaundice, abdominal pain, fatigue, loss of appetite, nausea, and weight loss.

Early diagnosis and treatment are essential to prevent progression and potential complications associated with liver diseases.

Contrast media are substances that are administered to a patient in order to improve the visibility of internal body structures or processes in medical imaging techniques such as X-rays, CT scans, MRI scans, and ultrasounds. These media can be introduced into the body through various routes, including oral, rectal, or intravenous administration.

Contrast media work by altering the appearance of bodily structures in imaging studies. For example, when a patient undergoes an X-ray examination, contrast media can be used to highlight specific organs, tissues, or blood vessels, making them more visible on the resulting images. In CT and MRI scans, contrast media can help to enhance the differences between normal and abnormal tissues, allowing for more accurate diagnosis and treatment planning.

There are several types of contrast media available, each with its own specific properties and uses. Some common examples include barium sulfate, which is used as a contrast medium in X-ray studies of the gastrointestinal tract, and iodinated contrast media, which are commonly used in CT scans to highlight blood vessels and other structures.

While contrast media are generally considered safe, they can sometimes cause adverse reactions, ranging from mild symptoms such as nausea or hives to more serious complications such as anaphylaxis or kidney damage. As a result, it is important for healthcare providers to carefully evaluate each patient's medical history and individual risk factors before administering contrast media.

Sulfur hexafluoride (SF6) is not typically a term used in medical definitions, but it is a colorless, odorless, non-flammable gas that is heavier than air. It is commonly used in the medical field for its magnetic resonance imaging (MRI) properties.

In MRI, SF6 is used as a contrast agent to improve the visualization of blood vessels and flow. When injected into a patient's bloodstream, the gas displaces oxygen in the blood, causing the blood vessels to appear darker on an MRI scan. This allows doctors to better see any abnormalities or blockages in the blood vessels.

It is important to note that sulfur hexafluoride should only be used under medical supervision and with appropriate precautions, as it can have adverse effects if not handled properly.

Keratin-7 is not a medical term itself, but it is a specific type of keratin protein that is often used in pathology as a marker for certain types of carcinomas. Keratins are a family of fibrous proteins that make up the structural framework of epithelial cells, which line the surfaces and glands of the body.

Keratin-7 is typically expressed in simple epithelia, such as those found in the gastrointestinal tract, pancreas, bile ducts, and respiratory and genitourinary tracts. It can be used as a marker to help identify carcinomas that arise from these tissues, such as adenocarcinomas of the pancreas or biliary system.

In medical terminology, keratin-7 positivity is often reported in the pathology report of a biopsy or surgical specimen to indicate the presence of this protein in cancer cells. This information can be helpful in determining the origin and behavior of the tumor, as well as guiding treatment decisions.

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults. It originates from the hepatocytes, which are the main functional cells of the liver. This type of cancer is often associated with chronic liver diseases such as cirrhosis caused by hepatitis B or C virus infection, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and aflatoxin exposure.

The symptoms of HCC can vary but may include unexplained weight loss, lack of appetite, abdominal pain or swelling, jaundice, and fatigue. The diagnosis of HCC typically involves imaging tests such as ultrasound, CT scan, or MRI, as well as blood tests to measure alpha-fetoprotein (AFP) levels. Treatment options for Hepatocellular carcinoma depend on the stage and extent of the cancer, as well as the patient's overall health and liver function. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or liver transplantation.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

Oral contraceptives, also known as "birth control pills," are medications taken by mouth to prevent pregnancy. They contain synthetic hormones that mimic the effects of natural hormones estrogen and progesterone in a woman's body, thereby preventing ovulation, fertilization, or implantation of a fertilized egg in the uterus.

There are two main types of oral contraceptives: combined pills, which contain both estrogen and progestin, and mini-pills, which contain only progestin. Combined pills work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant. Mini-pills work mainly by thickening cervical mucus and changing the lining of the uterus.

Oral contraceptives are highly effective when used correctly, but they do not protect against sexually transmitted infections (STIs). It is important to use them consistently and as directed by a healthcare provider. Side effects may include nausea, breast tenderness, headaches, mood changes, and irregular menstrual bleeding. In rare cases, oral contraceptives may increase the risk of serious health problems such as blood clots, stroke, or liver tumors. However, for most women, the benefits of using oral contraceptives outweigh the risks.

Spiral Computed Tomography (CT), also known as Helical CT, is a type of computed tomography scan in which the X-ray tube and detector rotate around the patient in a spiral path, capturing data as the table moves the patient through the scanner. This continuous spiral motion allows for faster and more detailed volumetric imaging of internal organs and structures, reducing the need for multiple slices and providing improved image reconstruction. It is commonly used to diagnose and monitor various medical conditions, including cancer, heart disease, and trauma injuries.

Keratin-19 is a type I acidic keratin that is primarily expressed in simple epithelia, such as the gastrointestinal tract, respiratory tract, and epidermal appendages (e.g., hair follicles, sweat glands). It plays an essential role in maintaining the structure and integrity of these tissues by forming intermediate filaments that provide mechanical support to cells.

Keratin-19 is often used as a marker for simple epithelial differentiation and has been implicated in various pathological conditions, including cancer progression and metastasis. Mutations in the KRT19 gene, which encodes keratin-19, have been associated with certain genetic disorders, such as epidermolysis bullosa simplex, a blistering skin disorder.

In summary, Keratin-19 is an important structural protein expressed in simple epithelia that plays a crucial role in maintaining tissue integrity and has implications in various pathological conditions.

Image enhancement in the medical context refers to the process of improving the quality and clarity of medical images, such as X-rays, CT scans, MRI scans, or ultrasound images, to aid in the diagnosis and treatment of medical conditions. Image enhancement techniques may include adjusting contrast, brightness, or sharpness; removing noise or artifacts; or applying specialized algorithms to highlight specific features or structures within the image.

The goal of image enhancement is to provide clinicians with more accurate and detailed information about a patient's anatomy or physiology, which can help inform medical decision-making and improve patient outcomes.

Gadolinium DTPA (Diethylenetriaminepentaacetic acid) is a type of gadolinium-based contrast agent (GBCA) used in medical imaging, particularly magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). It functions as a paramagnetic substance that enhances the visibility of internal body structures during these imaging techniques.

The compound Gadolinium DTPA is formed when gadolinium ions are bound to diethylenetriaminepentaacetic acid, a chelating agent. This binding helps to make the gadolinium ion safer for use in medical imaging by reducing its toxicity and improving its stability in the body.

Gadolinium DTPA is eliminated from the body primarily through the kidneys, making it important to monitor renal function before administering this contrast agent. In some cases, Gadolinium DTPA may cause adverse reactions, including allergic-like responses and nephrogenic systemic fibrosis (NSF) in patients with impaired kidney function.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Prostatic hyperplasia, also known as benign prostatic hyperplasia (BPH), is a noncancerous enlargement of the prostate gland. The prostate gland surrounds the urethra, the tube that carries urine and semen out of the body. When the prostate gland enlarges, it can squeeze or partially block the urethra, causing problems with urination, such as a weak stream, difficulty starting or stopping the flow, and more frequent urination, especially at night. Prostatic hyperplasia is a common condition as men age and does not necessarily lead to cancer. However, it can cause significant discomfort and decreased quality of life if left untreated. Treatment options include medications, minimally invasive procedures, and surgery.

Hepatectomy is a surgical procedure that involves the removal of part or all of the liver. This procedure can be performed for various reasons, such as removing cancerous or non-cancerous tumors, treating liver trauma, or donating a portion of the liver to another person in need of a transplant (live donor hepatectomy). The extent of the hepatectomy depends on the medical condition and overall health of the patient. It is a complex procedure that requires significant expertise and experience from the surgical team due to the liver's unique anatomy, blood supply, and regenerative capabilities.

Angiography is a medical procedure in which an x-ray image is taken to visualize the internal structure of blood vessels, arteries, or veins. This is done by injecting a radiopaque contrast agent (dye) into the blood vessel using a thin, flexible catheter. The dye makes the blood vessels visible on an x-ray image, allowing doctors to diagnose and treat various medical conditions such as blockages, narrowing, or malformations of the blood vessels.

There are several types of angiography, including:

* Cardiac angiography (also called coronary angiography) - used to examine the blood vessels of the heart
* Cerebral angiography - used to examine the blood vessels of the brain
* Peripheral angiography - used to examine the blood vessels in the limbs or other parts of the body.

Angiography is typically performed by a radiologist, cardiologist, or vascular surgeon in a hospital setting. It can help diagnose conditions such as coronary artery disease, aneurysms, and peripheral arterial disease, among others.

Polysaccharides are complex carbohydrates consisting of long chains of monosaccharide units (simple sugars) bonded together by glycosidic linkages. They can be classified based on the type of monosaccharides and the nature of the bonds that connect them.

Polysaccharides have various functions in living organisms. For example, starch and glycogen serve as energy storage molecules in plants and animals, respectively. Cellulose provides structural support in plants, while chitin is a key component of fungal cell walls and arthropod exoskeletons.

Some polysaccharides also have important roles in the human body, such as being part of the extracellular matrix (e.g., hyaluronic acid) or acting as blood group antigens (e.g., ABO blood group substances).

The parathyroid glands are four small endocrine glands located in the neck, usually near or behind the thyroid gland. They secrete parathyroid hormone (PTH), which plays a critical role in regulating calcium and phosphate levels in the blood and bones. PTH helps maintain the balance of these minerals by increasing the absorption of calcium from food in the intestines, promoting reabsorption of calcium in the kidneys, and stimulating the release of calcium from bones when needed. Additionally, PTH decreases the excretion of calcium through urine and reduces phosphate reabsorption in the kidneys, leading to increased phosphate excretion. Disorders of the parathyroid glands can result in conditions such as hyperparathyroidism (overactive glands) or hypoparathyroidism (underactive glands), which can have significant impacts on calcium and phosphate homeostasis and overall health.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

Secondary hyperparathyroidism is a condition characterized by an overproduction of parathyroid hormone (PTH) from the parathyroid glands due to hypocalcemia (low levels of calcium in the blood). This condition is usually a result of chronic kidney disease, where the kidneys fail to convert vitamin D into its active form, leading to decreased absorption of calcium in the intestines. The body responds by increasing PTH production to maintain normal calcium levels, but over time, this results in high PTH levels and associated complications such as bone disease, kidney stones, and cardiovascular calcification.

Brunner glands, also known as submucosal glands of Brunner, are tubulo-acinar exocrine glands located in the submucosa of the duodenum, which is the first part of the small intestine. These glands secrete alkaline mucus that helps neutralize the acidic chyme (partially digested food) entering from the stomach, providing a more favorable environment for the enzymes involved in nutrient absorption and protecting the duodenal mucosa from acid-induced damage.

... (FNH) is a benign tumor of the liver (hepatic tumor), which is the second most prevalent tumor of the ... Focal nodular hyperplasia's most recognizable gross feature is a central stellate scar seen in 60-70% of cases. Microscopically ... Imaging in Focal Nodular Hyperplasia at eMedicine Scalori, Astrid; Tavani, Alessandra; Gallus, Silvano; La Vecchia, Carlo; ... Chun Hsee, Li; McCall, John L.; Koea, Jonathan B. (2005). "Focal nodular hyperplasia: what are the indications for resection ...
Benign neoplasms include hepatocellular adenoma, hepatic hemangioma and focal nodular hyperplasia. The most common malignant ...
Focal nodular hyperplasia (FNH) is the second most common benign tumor of the liver. FNH is found in 0.2%-0.3% of adults ... focal nodular hyperplasia, and hepatocellular carcinoma. Molecular categorization via biopsy and pathological analysis aids in ... follicular nodular hyperplasia (FNH), and hypervascular metastasis), but maybe occult or difficult to characterize on portal ...
"A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia". Gastroenterology. 124 (3 ...
Hepatic adenomas may be misidentified as focal nodular hyperplasia in diagnostic imaging, though this condition is rare. ... which is otherwise commonly observed in focal nodular hyperplasia. Unlike common hepatic adenomas related to oral contraception ...
These malignancies can live alongside other liver tumors such as hepatic cysts, hepatic angiosarcoma, focal nodular hyperplasia ... The three types include focal, multifocal, and diffuse. Focal hepatic hemangiomas are large tumors that are present at birth ... Focal hemangiomas can resolve without treatment. Multifocal hepatic hemangiomatosis have GLUT-1 expressed as multiple lesions, ... The infants were classified as having either focal (8), multiple (12), or diffuse (6) lesions, or injuries. All of the infants ...
5 focal nodular hyperplasias and 1 liver cell carcinoma. Brambilla G, Martelli A (December 2002). "Are some progestins ... 437-. ISBN 978-0-08-049789-1. Kanimoto Y, Okada K (November 1991). "[Antiandrogen therapy of benign prostatic hyperplasia-- ... widely used as a means of androgen deprivation therapy in the treatment of prostate cancer and benign prostatic hyperplasia ( ...
... focal nodular hyperplasia, and hemangioma. FibroTest (FibroSure in the USA) and FibroMax are non-invasive tests using a blood ...
... a Belgian firearms manufacturer Focal nodular hyperplasia Fools and Heroes, a British live-action role playing system Sidus FNH ...
Echinococcal cyst Focal fatty change Focal nodular hyperplasia Hepatoblastoma Infiltrative liver disease Inflammatory ... unlike other benign liver tumors such as hemangioma and focal nodular hyperplasia, hepatic adenomas have a small but meaningful ... pseudotumor Leiomyosarcoma Lymphoma Nodular regenerative hyperplasia Hepatic adenomas may be sub-classified according to ...
... benign focal nodular hyperplasia) or absent, with posterior acoustic enhancement effect (cysts), have distinct delineation ( ... type is also described which is difficult to discriminate from liver nodular reconstruction in cirrhosis. Typically HCC invades ...
... and focal nodular hyperplasia (FNH). Chronic liver diseases like chronic hepatitis, chronic alcohol abuse or chronic toxic ... other rare disorders like focal nodular hyperplasia, Hepatic fibrosis, peliosis hepatis and veno-occlusive disease. Liver ...
Focal interstitial fibrosis presents a unique challenge when differentiating from malignant nodular GGOs on CT imaging. It is ... and atypical adenomatous hyperplasia (AAH). One large review study found that 80% of nodular GGOs which were present on ... GGO can be used to describe both focal and diffuse areas of increased density. Subtypes of GGOs include diffuse, nodular, ... Diffuse Mycoplasma pneumoniae Chlamydophila pneumoniae Legionella pneumophilia Focal or nodular Mycobacterium Nocardia Septic ...
Mis-migration of neurons can also result in bilateral periventricular nodular heterotopia, a disease recognized by neuronal ... Examples include ectopic neurogenesis, microencephaly, and altered cell survival resulting in areas of hyperplasia, reduced ... and focal/subependymal heterotopia. Kallmann syndrome is recognized by anosmia associated with mental retardation, hypogonadism ...
In contrast, a uterine adenomyoma is an isolated nodular mass of endometrial tissue with surrounding smooth muscle, either ... Gallbladder adenomyomatosis is a benign disease of the gallbladder characterized by hyperplasia of the mucosal epithelium and ... Women with uterine adenomyomas (focal adenomyosis) more commonly have co-existing endometriosis and a higher likelihood of ... Uterine adenomyoma is the focal form of uterine adenomyosis. Adenomyosis most commonly presents with numerous small collections ...
One or several areas of nodular thickening may be seen on the luminal surface in the gross examination of the fibrous wall of a ... The cyst is lined mostly or entirely by non-keratinizing squamous epithelium which display varying amounts of hyperplasia with ... Focal areas of mucus cells or rarely, ciliated columnar cells may be found in the epithelial lining of dentigerous cysts. In ...
Cutaneous focal mucinosis Cutaneous lupus mucinosis (papular and nodular mucinosis in lupus erythematosus, papular and nodular ... Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns Cutaneous lymphoid hyperplasia with nodular pattern ( ... Focal palmoplantar and gingival keratosis Focal palmoplantar keratoderma with oral mucosal hyperkeratosis (focal epidermolytic ... nodular pattern of cutaneous lymphoid hyperplasia) Diffuse large B-cell lymphoma (primary cutaneous large B-cell lymphoma) ...
Hyperimmunoglobulinemia D with periodic fever Hyperimmunoglobulinemia E Hyperinsulinism due to focal adenomatous hyperplasia ... Hereditary t Hereditary nodular heterotopia Hereditary non-spherocytic hemolytic anemia Hereditary pancreatitis Hereditary ... focal Hyperkalemia Hyperkalemic periodic paralysis Hyperkeratosis lenticularis perstans of Flegel Hyperkeratosis lenticularis ... Hemi 3 syndrome Hemifacial atrophy agenesis of the caudate nucleus Hemifacial atrophy progressive Hemifacial hyperplasia ...
"The EFG of Nodular Melanomas , MoleMap New Zealand". The EFG of Nodular Melanomas , MoleMap New Zealand. Archived from the ... The brown pigment is a focal deposition of melanin. A dermatoscope Malignant Melanoma, right posterior thigh Melanoma in situ, ... a medial right temple with adjacent sebaceous hyperplasia, lateral Malignant Melanoma in situ, left anterior shoulder marked ... Early signs of melanoma are changes to the shape or color of existing moles or, in the case of nodular melanoma, the appearance ...
"Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy ... "Long-term follow-up of giant nodular posterior scleritis simulating choroidal melanoma". Arch Ophthalmol. 118 (9): 1290-2. doi: ... "Pseudoepitheliomatous hyperplasia mimicking ocular surface squamous neoplasia following cultivated limbal epithelium ... "Spontaneous disappearance of presumed retinal astrocytic hyperplasia". Retina. 22 (2): 237-9. doi:10.1097/00006982-200204000- ...
Tracy RE, White S (February 2002). "A method for quantifying adrenocortical nodular hyperplasia at autopsy: some use of the ... This stage corresponds to more severe generalized and focal areas of arteriolar narrowing, changes in the arteriolar and ... Persistently elevated blood pressure leads to intimal thickening, hyperplasia of the media wall, and hyaline degeneration in ... focal neurologic signs, and alterations in mental status. Untreated, hypertensive encephalopathy may progress to stupor, coma, ...
... nodular dermatofibrosis). They had a similar pattern of tumorigenesis to human BHD in that the skin lesions were heterozygous ... cutaneous focal mucinosis, cutaneous leiomyoma, breast cancer, tonsillar cancer, colorectal cancer, sarcoma of the leg, lung ... they also are prone to endometrial and salivary gland clear-cell hyperplasia as well as rhabdomyolysis. Homozygotes do not ...
... lymph nodes have areas of hyperplasia, focal necrosis, and small granulomas; spleen shows atrophy of white pulp with congested ... It may also evidence signs and symptoms caused by nodular or infiltrative lesions in the skin, central nervous system, kidney, ... this disorder is characterized by hyperplasia of plasma cells, florid hyperplasia of lymph node follicles, and infectious ... Kunitomi A, Hasegawa Y, Asano N, Kato S, Tokunaga T, Miyata Y, Iida H, Nagai H (May 2018). "EBV-positive Reactive Hyperplasia ...
... focal segmental, 1; 603278; ACTN4 Glomerulosclerosis, focal segmental, 2; 603965; TRPC6 Glomerulosclerosis, focal segmental, 3 ... TP53 Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency; 202010; CYP11B1 Adrenal hyperplasia, congenital, ... PRKAR1A Pigmented nodular adrenocortical disease, primary, 2; 610475; PDE11A Pigmented paravenous chorioretinal atrophy; 172870 ... KLKB1 Focal cortical dysplasia, Taylor balloon cell type; 607341; TSC1 Focal dermal hypoplasia; 305600; PORCN Folate ...
Being a nodular signaling molecule, PAK1 operates to converging station of a large number of signals triggered by proteins on ... "Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and ... "P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium ...
The disease in dogs is usually nodular skin lesions of the head and trunk. Aspergillosis* is a fungal disease that in dogs is ... Rage syndrome is a rare inherited seizure disorder characterized by explosive aggression and focal neurologic symptoms. It is ... Reproductive diseases Prostate disease* in dogs includes benign prostatic hyperplasia (BPH), prostatitis (infection of the ... The leaflets of the valve become thickened and nodular, leading to mitral valve regurgitation and volume overload of the left ...
Focal nodular hyperplasia (FNH) is a benign tumor of the liver (hepatic tumor), which is the second most prevalent tumor of the ... Focal nodular hyperplasias most recognizable gross feature is a central stellate scar seen in 60-70% of cases. Microscopically ... Imaging in Focal Nodular Hyperplasia at eMedicine Scalori, Astrid; Tavani, Alessandra; Gallus, Silvano; La Vecchia, Carlo; ... Chun Hsee, Li; McCall, John L.; Koea, Jonathan B. (2005). "Focal nodular hyperplasia: what are the indications for resection ...
Focal nodular hyperplasia (FNH) is the second most common tumor of the liver, surpassed in prevalence only by hepatic ... encoded search term (Focal Nodular Hyperplasia (FNH) Imaging and Diagnosis) and Focal Nodular Hyperplasia (FNH) Imaging and ... Focal nodular hyperplasia usually displays a homogeneous signal intensity on MRI (see the image below). [30, 27, 2, 31, 8, 32, ... Focal Nodular Hyperplasia (FNH) Imaging and Diagnosis Updated: Mar 04, 2021 * Author: Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR; ...
Citation: Donadon M, Di Tommaso L, Roncalli M, Torzilli G. Multiple focal nodular hyperplasias induced by oxaliplatin-based ... Donadon M, Di Tommaso L, Roncalli M, Torzilli G. Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy ... Figure 3 Radiological imaging of case 2. A: The abdominal contrast-enhanced computed tomography showed multiple focal liver ... The abdominal contrast-enhanced magnetic resonance imaging showed multiple bilateral focal liver lesions (arrows); B: The ...
Complete spontaneous regression of giant focal nodular hyperplasia of the liver: Magnetic resonance imaging evaluation with ... Core tip: We present a patient with focal nodular hyperplasia (FNH) of the liver who was followed up for 7 years. A 26-year-old ... Mamone G, Caruso S, Cortis K, Miraglia R. Complete spontaneous regression of giant focal nodular hyperplasia of the liver: ... Complete spontaneous regression of giant focal nodular hyperplasia of the liver: Magnetic resonance imaging evaluation with ...
Focal Nodular Hyperplasia (FNH ...
Best Image focal nodular hyperplasia of liver symptoms treatment causes Focal nodular hyperplasia (FNH) is the ... Focal Nodular Hyperplasia Of Liver Symptoms Treatment Causes. Thank you for visiting Focal Nodular Hyperplasia Of Liver ... Description from Focal Nodular Hyperplasia Of Liver Symptoms Treatment Causes pictures wallpaper :. Focal Nodular Hyperplasia ... Focal Nodular Hyperplasia Of Liver Symptoms Treatment Causes was posted in March 1, 2015 at 11:00 am. This HD Wallpaper Focal ...
To assess the value of Hepatobiliary phase MRI (HPB-MRI) to differentiate FNH and HCA, and evaluate its impact on diagnostic accuracy, diagnostic confidence, inter-observer variability, and patient clinical management. Forty-nine patients referred for Gd-BOPTA-enhanced MRI were retrospectively included in this IRB-approved study, with a total of 119 lesions-90 FNH and 29 HCA. Two observers separately assessed in 2 distinct randomized reading sessions the performance of MRI with (HBP-MRI) or without (conventional MRI) the use of HBP images. Each lesion was ranked with a 5-point scale (from 1 Typical FNH to 5 Certainly not a FNH). Sensitivity, specificity, overall accuracy, and inter-observer agreement for the differentiation of FNH from HCA were calculated and compared between conventional and HBP-MRI. Both sensitivity (respective values of 38.9% and 97.8%), overall accuracy (respective values of 53.8% and 98.3%), and inter-observer agreement (respective values of Kappa 0.56 and 0.88) w
Usefulness of EOB-MRI for focal nodular hyperplasia (FNH) diagnosis Aichi Cancer Center Hospital. Drs. Shohei Chatani and ...
i. Focal nodular hyperplasia. 1. 2. 2. 2. 2. 2. ii. Hepatocellular adenoma. 1. 3. 3. 3. 3. 4. ... Endometrial hyperplasia. 1. 1. 1. 1. 1. 1. Endometrial cancer. This condition is associated with increased risk for adverse ...
Focal nodular hyperplasia. Focal nodular hyperplasia. Focal nodular hyperplasia. Focal nodular hyperplasia. ...
Focal nodular hyperplasia Gastrointestinal symptoms (such as abdominal pain, cramps, and bloating) Hirsutism Infertility after ... Headaches with focal neurological symptoms such as aura Uncontrolled hypertension Known or suspected carcinoma of the breast or ... Women with migraine (particularly migraine/headaches with focal neurological symptoms such as aura) who take combination oral ... did not reveal any hyperplasias or malignancies. Endometrial malignancy is rare in this age group, so change in the risk is ...
The most common use for a liver scan is to diagnose a condition called benign focal nodular hyperplasia, or FNH, which causes a ...
Focal nodular hyperplasia (FNH). * Gilberts syndrome. * Glycogen storage disease. * Hepatic adenomas. * Hepatic encephalopathy ...
Focal nodular hyperplasia; HCC: Hepatocellular carcinoma; HVPG: Hepatic vein portal pressure; MM: Malignant melanoma; MTT: Mean ... Focal liver lesion. Patients with focal liver lesion and subsequent final diagnosis/HCC, CCC, PCA, CRC, BC, MM, FNH. Sequoia ... Focal liver lesion. Patients with diagnosed focal liver lesion/malignant versus benign. Acuson Sequoia, S2000 or S3000 and ... PC, focal AIP. Patients with diagnosis of AIP vs histologically proved PC. Acuson Sequoia 512, S200/SonoVue/VueBox. The ...
Hemangiomas and focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging Jacek ... Hemangiomas and focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging Jacek ... Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power ... Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power ...
Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg. 2010. 27(1):46-55. [QxMD MEDLINE Link]. ... 20] I-HCA subtype was previously referred to as telangiectatic focal nodular hyperplasia (FNH), as it was thought to be a type ... Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, ... Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis. Eur J ...
Focal nodular hyperplasia *Cavernous transformation of the portal vein with pericholedochal varices *Hepatocellular carcinoma * ...
Focal nodular hyperplasia. Correct Answer. A. HCC Explanation. When a patient has a raised serum alpha-fetoprotein level, it is ... The focal hypoechoic area anterior to the portal vein suggests focal sparing, which is a phenomenon where certain areas of the ... Focal fatty liver refers to the accumulation of fat in specific areas of the liver. In this case, it is most commonly found ... You will carefully evaluate the liver to rule out the presence of any focal mass because of which TRUE statement below?. *. A. ...
Focal nodular hyperplasia. *Cysts. *Abscess. *Hepatocellular carcinoma. *Metastatic diseases to the liver ...
Focal nodular hyperplasia of the liver: the solitary cirrhotic liver nodule T. S. Wilson and J. W. Macgregor ...
Focal Nodular Hyperplasia-Like Lesions With Glypican-3 Positivity in Infancy. Berklite, L; Shenoy, A; Hollowell, M; Fung, B; ...
Focal nodular hyperplasia (FNH): oral contraceptives (not associated with FNH pathogenesis; associated with larger and more ... Nodular regenerative hyperplasia: azathioprine, busulphan, bleomycin, cyclophosphamide, chlorambucil, cysteine arabinoside, ...
Pathology, predisposinig conditions and evolution of: focal nodular hyperplasia, hepatocellular adenoma, hepatocellular ... Parathyroid: parathyroid hyperplasia, adenoma and carcinoma.. Adrenal cortex. Hyper- and hypofunction and their pathologic ... Prostatitis, stromal and glandular hyperplasia of the prostate, prostatic carcinoma (including Gleasons grade and score). ... Hyper- e hypothyroidism and their association with diffuse and multinodular hyperplasia: Graves-Basedow disease, multinodular ...
Examples include liver cysts, haemangioma, adenoma and focal nodular hyperplasia. Liver surgery can also be performed to treat ...
Focal nodular hyperplasia is a combination of several types of cells.. ICD-9-CM Code Assignment. Primary liver cancer is ...
The growths are called by the name of the process: "Focal nodular hyperplasia". Lesions of focal nodular hyperplasia are benign ...
Across practices, Eovist is used to differentiate focal nodular hyperplasia (FNH) from hepatic adenoma (HCA). Mohanned Alnammi ... This involves six focal pancreatic abnormalities that when detected will aid in early disease detection, early disease ... findings include that the technique is safe and fairly high yield for lesions 20 mm or less and that features such as nodular. ...
Focal nodular hyperplasia of the liver: pathological analysis of 11 cases. Hepatobiliary Pancreat Dis Int. 2004 May. 3(2):199- ... Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics. 1996 Mar. 16(2):369-88. [QxMD MEDLINE ... Its association with focal nodular hyperplasia. Cancer. 1987 Dec 15. 60(12):3049-55. [QxMD MEDLINE Link]. ... Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. J Reprod Med ...
Focal nodular hyperplasia (FNH) is the second most prevalent t... Read More. Created for people with ongoing healthcare needs ... A recent ct scan noticed a benign appearing mass on my liver that suggests focal nodular hyperplasia. im having an mri to ...
Everson RB, Fraument J. Familial glioblastoma with hepatic focal nodular hyperplasia. Cancer 1976; 38: 310-3. ...
  • Focal nodular hyperplasia (FNH) is a benign tumor of the liver (hepatic tumor), which is the second most prevalent tumor of the liver (the first is hepatic hemangioma). (wikipedia.org)
  • The most common use for a liver scan is to diagnose a condition called benign focal nodular hyperplasia, or FNH, which causes a non-cancerous mass in the liver. (medlineplus.gov)
  • Moreover, it is also difficult to distinguish HCC from benign hepatocellular tumors such as focal nodular hyperplasia and hepatocellular adenoma [ 11 , 12 ]. (e-ultrasonography.org)
  • Additionally, fibrolamellar carcinoma and focal nodular hyperplasia share several features, such as a stellate central scar on imaging studies and copper accumulation on histological examination, that have prompted some to suggest that focal nodular hyperplasia may be a benign precursor lesion to fibrolamellar carcinoma. (medscape.com)
  • Its association with focal nodular hyperplasia. (medscape.com)
  • Hepatocellular adenomas (HCAs) are also known as hepatic adenomas, telangiectatic focal nodular hyperplasia (FNH) or, less commonly, liver cell adenomas. (medscape.com)
  • Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? (unil.ch)
  • Other patterns include telangiectatic, hyperplastic-adenomatous, and lesions with focal large-cell dysplasia. (wikipedia.org)
  • ACG clinical guideline: The diagnosis and management of focal liver lesions. (msdmanuals.com)
  • Today's discussion is on focal liver lesions. (medscape.com)
  • What do we do with these focal liver lesions? (medscape.com)
  • To investigate the capacity of Superb Microvascular Imaging (SMI) to detect microvascular details and to explore the different SMI features in various focal liver lesions (FLLs) and the correlation between SMI and microvessel density (MVD). (biomedcentral.com)
  • Early detection and diagnosis are important for the prevention and treatment of HCC, and ultrasound (US) has been recommended as the first imaging modality for screening focal liver lesions (FLLs) because it is noninvasive and widely available. (biomedcentral.com)
  • Basing on their characteristic appearance, common B-mode and color Doppler US can detect focal liver lesions, such as focal nodular hyperplasia (FNH) with a spoke-wheel shaped vascular pattern. (biomedcentral.com)
  • According to the American Association for the Study of Liver Diseases (AASLD) guidelines, biopsy is a diagnostic option for focal hepatic lesions depending on the Liver Imaging Reporting and Data System (LI-RADS) category. (e-ultrasonography.org)
  • Focal hepatic lesions on MRI were evaluated according to LI-RADS version 2018. (e-ultrasonography.org)
  • Histologically, the nodular lesions in the ileum showed severe granulomatous enteritis with large areas of necrosis and numerous multinucleated giant cells (Figure, panel A). Ziehl-Neelsen stain demonstrated large numbers of acid-fast bacilli in macrophages and multinucleated giant cells in the intestine ( Figure , panel B). The mesenteric lymph node also exhibited a granulomatous inflammation with multinucleated giant cells. (cdc.gov)
  • Focal nodular hyperplasia (FNH) is a polyclonal tumour-like hepatic lesion characterised by parenchymal nodules, connective tissue septa without interlobular bile ducts, pronounced ductular reaction and inflammation. (aabioetica.org)
  • In large regenerative nodules, focal nodular hyperplasia and liver cell adenoma CD34-positive capillaries reflect afferent parts and CD 34-negative sinusoids the efferent parts of the parenchymal vascular bed. (springer.com)
  • 2016 ) Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. (neurotree.org)
  • Histological examination of the nodules suggested focal nodular hyperplasia (FNH)-like hyperplasia. (bvsalud.org)
  • Focal nodular hyperplasia (FNH) is the second most common tumor of the liver, surpassed in prevalence only by hepatic hemangioma . (medscape.com)
  • Focal nodular hyperplasia's most recognizable gross feature is a central stellate scar seen in 60-70% of cases. (wikipedia.org)
  • Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium. (umassmed.edu)
  • You may find that these patients have a characteristic central scar called "focal nodular hyperplasia. (medscape.com)
  • Imaging Found a Focal Liver Lesion--Now What? (medscape.com)
  • It is not unusual for these diagnostics to reveal what may be a focal liver lesion. (medscape.com)
  • A total of 145 High-risk patients for hepatocellular carcinoma (HCC) who underwent magnetic resonance imaging (MRI) followed by CNB for a focal hepatic lesion preoperatively were retrospectively enrolled. (e-ultrasonography.org)
  • Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. (medscape.com)
  • Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change. (medscape.com)
  • Hepatocellular carcinoma associated with focal nodular hyperplasia: report of a case with clonal analysis. (ntu.edu.tw)
  • Increasingly, focal nodular hyperplasia is being recognized as an incidental finding because of the widespread use of diagnostic imaging for unrelated conditions. (medscape.com)
  • Mamone G, Caruso S, Cortis K, Miraglia R. Complete spontaneous regression of giant focal nodular hyperplasia of the liver: Magnetic resonance imaging evaluation with hepatobiliary contrast media. (wjgnet.com)
  • A tumour-like development made of various cell types (connective tissue cells, hepatocytes, and bile duct cells) is called Focal Nodular Hyperplasia (FNH). (acko.com)
  • It starts as a diffuse enlargement of the thyroid gland and ends in a nodular enlarged thyroid. (intechopen.com)
  • Histopathological examination conducted at this time also suggested FNH-like hyperplasia. (bvsalud.org)
  • Focal nodular hyperplasia, or FNH, is a tumor-like growth of several cell types. (ucsf.edu)
  • Additionally, the rabbit had mild suppurative splenitis, mild lymphohistiocytic to granulomatous hepatitis, mild focal lymphocytic interstitial orchitis, and a hyperplasia of the myeloic cell line in the femoral and sternal bone marrow. (cdc.gov)
  • [ 7 ] Knowledge of preceding treatment and the finding of other therapy-related changes, such as glandular atrophy, as well as basal cell hyperplasia, should alert to this differential. (medscape.com)
  • It is an appetite stimulant focal nodular hyperplasia have growth and, crucially, teach your body to burn fat for energy. (htdig.org)
  • Nodular goiter is one of the most common endocrine disorders affecting the thyroid gland. (intechopen.com)
  • Donadon M, Di Tommaso L, Roncalli M, Torzilli G. Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy. (wjgnet.com)
  • Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. (nih.gov)
  • Association of hepatocellular adenoma and focal nodular hyperplasia of the liver in a woman on oral contraceptives]. (nih.gov)
  • Benign liver tumors include hepatocellular adenomas (HCAs), hemangiomas, hamartomas, and focal nodular hyperplasia (FNH). (medscape.com)
  • Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia. (pitt.edu)
  • Extensive hepatocellular adenomatosis (HA) and focal nodular hyperplasia (FNH) represent a proliferation of hepatic cells that occurs most frequently in women. (pitt.edu)
  • 14. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. (nih.gov)
  • 5. [Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases]. (nih.gov)
  • 19. [Clinical analysis of 38 cases of hepatic focal nodular hyperplasia and literature review]. (nih.gov)
  • They are adenomas, hemangiomas and focal nodular hyperplasia. (nih.gov)
  • [ 6 ] No lobar predilection exists, and these tumors may be associated with focal nodular hyperplasia. (medscape.com)
  • La tinció immunohistoquímica es fa servir en el diagnòstic de cèl·lules anormals com les que es troben en els tumors cancerosos, entre altres afeccions. (wikipedia.org)
  • 1. [Diagnosis and treatment of focal nodular hyperplasia of liver: report of 23 cases]. (nih.gov)
  • 3. [Diagnosis and treatment of focal nodular hyperplasia of liver]. (nih.gov)
  • 11. The role of diagnostic imaging and liver biopsy in the diagnosis of focal nodular hyperplasia in children. (nih.gov)
  • ACG clinical guideline: The diagnosis and management of focal liver lesions. (msdmanuals.com)
  • Focal nodular hyperplasia: what are the indications for resection? (wikipedia.org)
  • 4. The value of liver resection for focal nodular hyperplasia: resection yes or no? (nih.gov)
  • Other patterns include telangiectatic, hyperplastic-adenomatous, and lesions with focal large-cell dysplasia. (wikipedia.org)
  • Mamone G, Caruso S, Cortis K, Miraglia R. Complete spontaneous regression of giant focal nodular hyperplasia of the liver: Magnetic resonance imaging evaluation with hepatobiliary contrast media. (wjgnet.com)
  • Purpose: To characterize imaging features of histologically proven hepatic adenoma (HA) as well as histologically and/or radiologically proven focal nodular hyperplasia (FNH) using delayed hepatobiliary MR imaging with 0.05 mmol/kg gadoxetic acid. (uni-luebeck.de)
  • When they are larger than 2 cm they may have the hallmark characteristic of peripheral nodular discontinuous enhancement and demonstrate progressive centripetal filling. (medscape.com)
  • As with contrast enhanced CT, they demonstrate peripheral nodular enhancement on arterial phase images with centripetal filling in the delayed phase. (medscape.com)
  • Note that the hemangioma is hyperintense on T2 weighted images and demonstrates peripheral nodular enhancement with progressive infilling with contrast enhancement. (medscape.com)
  • These images reveal the pathognomonic features of a hemangioma, namely, peripheral nodular enhancement and progressive centripetal fill-in (arrow). (medscape.com)
  • Increasingly, focal nodular hyperplasia is being recognized as an incidental finding because of the widespread use of diagnostic imaging for unrelated conditions. (medscape.com)
  • 2. [Focal nodular hyperplasia of the liver: a clinical study of 48 patients]. (nih.gov)
  • 17. [Clinical features of surgically resected focal nodular hyperplasia of the liver]. (nih.gov)
  • Findings probably favor focal nodular hyperplasia, or less likely hepatic adenoma. (cancer.org)
  • 7. [Surgical management of nodular hyperplasia tumor-like hepatic lesions: a study of 72 cases]. (nih.gov)
  • With a suspicion of malignancy, a surgical biopsy was performed which revealed a focal nodular hyperplasia (FNH) without malignancy. (2ndlifelavender.com)
  • 8. Histologic scoring of liver biopsy in focal nodular hyperplasia with atypical presentation. (nih.gov)
  • There is uncertainty regarding the role, if any, of oral contraceptive steroids in the development of focal nodular hyperplasia of the liver. (nih.gov)
  • Focal nodular hyperplasia's most recognizable gross feature is a central stellate scar seen in 60-70% of cases. (wikipedia.org)
  • Although various chemical agents and drugs have been considered as possible etiologic factors in the development of focal nodular hyperplasia of the liver, cases occurring after intraconazole therapy have not been reported before. (nih.gov)
  • 18. Focal nodular hyperplasia of the liver in children: A report of 2 cases. (nih.gov)
  • Apart from the theoretical considerations with regard to the pathogenesis of nodular hyperplasia of the liver, this case could gain practical importance, as it shows a new adverse effect of a drug that has been used in more than 34 million patients over the past 10 years. (nih.gov)
  • 12. Management and algorithm for focal nodular hyperplasia of the liver in children. (nih.gov)
  • Current information suggests that skin tumor promoters are not mutagenic but bring about a number of important epigenetic changes, such as epidermal hyperplasia, and an increase in polyamines, prostaglandins and dark basal keratinocytes as well as other embryonic conditions. (nih.gov)
  • A 38-year-old woman developed focal nodular hyperplasia of the liver after she had received a 4-month treatment with intraconazole 200 mg/d for a fungal infection of her fingernails. (nih.gov)
  • Focal fatty infiltration adjacent to the fissure for the falciform ligament involving the medial segment of the left hepatic lobe. (cancer.org)